
severity of a specific symptom, with ratings ranging from 0
to 3. The BDI-II is a widely used self-report measure of
depression with high internal consistency, ranging from .73
to .92 (Beck et al. 1996).
State-Trait Anxiety Inventory-Trait (STAI-T; Spielberger
et al. 1983)
Self-reported trait anxiety, the general tendency to expe-
rience anxiety in daily life, was assessed using the 20-item
STAI-T. Each item is rated on a 4-point scale (1 = almost
never; 4 = almost always). The STAI-T has shown
excellent internal consistency (a = .90) and test–retest
reliability ranging from .73 to .86 (Spielberger et al. 1983).
Results
Participant Characteristics
Table 1 presents demographic and clinical characteristics
for the four groups of participants. The mean age of par-
ticipants was 35.95 (SD = 11.12), and one-third of the
participants were male. As expected, the four groups dif-
fered significantly in BDI-II scores, F(3,511) = 399.76,
p \ .001, with the MDD group obtaining significantly
higher BDI-II scores than did the CTL, RMD, and SAD
groups. The SAD participants had higher BDI-II scores
than did the RMD participants, who in turn had higher
BDI-II scores than did the CTL participants. The four
diagnostic groups also differed in trait anxiety levels,
assessed by the STAI-T, F(3,435) = 280.04, p \ .001. All
four groups differed significantly from each other on STAI-
T scores in the order MDD, SAD, RMD, and CTL.
Unexpectedly, diagnostic groups differed in mean age;
however, age was not found to be significantly associated
with use of any of the three emotion regulation strategies
we investigated (r’s =-.03–.02, all ps [.05).
Given that we focused only on one anxiety disorder in
the present study, we also examined rates of comorbidity
of other anxiety disorders besides SAD among the MDD
and SAD groups. One quarter (24.5 %) of depressed
participants had at least one or more current comorbid
anxiety disorders. In contrast, 25.9 % of socially anxious
individuals and 8.4 % of participants in the RMD group
met criteria for a comorbid anxiety disorder. MDD, RMD
and SAD groups did not differ significantly in the pres-
ence of comorbid anxiety disorders, V
2
= 7.43, p [ .05,
thus differences between the MDD, RMD and SAD
groups in emotion regulation were not confounded by
differential rates of other comorbid anxiety disorders in
these groups.
Use of Emotion Regulation Strategies
Table 1 presents mean scores on the RRS, ERQ-suppres-
sion, and ERQ-reappraisal measures by diagnostic group.
3
A multivariate analysis of variance (MANOVA) was
conducted to test the hypothesis that the CTL, RMD,
MDD, and SAD groups differ in the frequency with which
they report using each strategy. The MANOVA yielded
significant differences among the groups in the use of these
strategies, Wilks’s K = .48, F(9,978.5) = 38.55, p =
.000, g
2
= .22. Analyses of variance (ANOVAs) were
conducted on each dependent variable as follow-up tests to
the MANOVA. The three ANOVAs all yielded significant
group differences (RRS: F(3,538) = 175.06, p \ .001;
ERQ-suppression: F(3,413) = 7.59, p \ .001; ERQ-reap-
praisal: F(3,410) = 23.56, p \ .001). In follow-up analy-
ses for each emotion regulation strategy, we first contrasted
both clinical groups (MDD and SAD) with the CTL group.
As expected, compared with the CTL participants, partic-
ipants with a disorder (MDD and SAD participants com-
bined), exhibited higher scores on the RRS, t(492) =
17.69, p \ .001, d = 1.75, and the ERQ-suppression scale,
t(366) = 4.54, p \ .001, d = .50, and lower scores on the
ERQ reappraisal scale, t(368) = 6.70, p \ .001, d = .76.
We then conducted planned comparisons to evaluate
whether the use of rumination is specific to MDD and
expressive suppression specific to SAD. Indeed, the MDD
group obtained significantly higher scores on the RRS than
did the SAD group, t(244) = 6.19, p \ .001, d = .88.
Moreover, there was evidence for specificity of expressive
suppression to SAD: SAD participants exhibited signifi-
cantly higher ERQ-suppression scores than did MDD par-
ticipants, t(190) = 3.00, p = .003, d = .45. Finally, MDD
participants had lower levels of ERQ-reappraisal than did
participants diagnosed with SAD, t(188) = 2.02, p = .04,
d = .31.
To test the third hypothesis that greater use of rumination
and expressive suppression, and decreased use of reap-
praisal, is stable following recovery from MDD, planned
comparisons were conducted contrasting MDD, RMD, and
CTL groups in their mean use of each strategy. In partial
support of our hypothesis, the RMD participants obtained
higher scores on the RRS than did CTLs, t(294) = 6.27,
p \ .001, d = 1.01, but had lower RRS scores than did the
3
As data on suppression and reappraisal was not collected until mid-
way into enrollment for the study, this resulted in smaller sample
sizes for analyses of these variables. Individuals missing this data
were included in analyses of diagnostic group differences in
rumination frequency, as well as in the SEM analyses, as missing
data on these emotion regulation variables was missing at random.
972 Cogn Ther Res (2013) 37:968–980
123